Please use this identifier to cite or link to this item: http://dspace.dtu.ac.in:8080/jspui/handle/repository/16832
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVERMA, SAUMYA-
dc.date.accessioned2019-11-11T09:45:31Z-
dc.date.available2019-11-11T09:45:31Z-
dc.date.issued2019-06-
dc.identifier.urihttp://dspace.dtu.ac.in:8080/jspui/handle/repository/16832-
dc.description.abstractThe vaccines of polio are being used to halt poliomyelitis. They are of two types: inactivated poliovirus which is taken by injection and weakened poliovirus which is taken by mouth. To study the mechanism of the reversion of genes in live poliovirus in humans, the study of molecular evolution has to be done. The results came out from the recent vaccine try out that the rates of the substitution for the VP1 are higher for the isolates of sabin which is compared with the wild type. In polio transmission patterns geographical variation is important. Major Histocompatibility Complex class I binding prediction tool and CD8+ immunogenicity prediction tool are being used for the prediction of class I epitopes. Major Histocompatibility Complex class II binding prediction tool and CD4+ immunogenicity prediction tool are being used for the prediction of class II epitopes. Population coverage of the epitopes of MHC I and MHC II binding peptide was preconcieved in Indian population. Many population coverage epitopes were selected for each serotype. Epitopes were selected for VP1, VP2, VP3, VP4. A combinatorial epitope prediction would be used as a therapeutic vaccine for polio.en_US
dc.language.isoenen_US
dc.relation.ispartofseriesTD-4645;-
dc.subjectEPITOPE PREDICTIONen_US
dc.subjectTHERAPEUTIC VACCINEen_US
dc.subjectHISTOCOMPATIBILITY COMPLEXen_US
dc.subjectPOLIOen_US
dc.titleEPITOPE PREDICTION AS THERAPEUTIC VACCINE FOR POLIOen_US
dc.typeThesisen_US
Appears in Collections:M.E./M.Tech. Bio Tech

Files in This Item:
File Description SizeFormat 
2k17bio07.pdf1.57 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.